Patents by Inventor Alan D. Bettermann

Alan D. Bettermann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7115753
    Abstract: Disclosed are triaryl cationic compounds that exhibit broad spectrum antibiotic and antifungal activity, pharmaceutical compositions containing the compounds, and methods of treating bacterial and fungal infections using the compounds. The compounds were initially isolated by screening a 25,000-member bacterial artificial chromosome (BAC) library of environmental (eDNA) from soil. At least one clone produced a dark brown melanin-like compound that was found to have antibiotic activity. The compounds were isolated and synthesized de novo. From within the positive clone, a single open reading frame that shares extensive sequence similarity with members of the 4-hydroxyphenylpyruvate family of enzymes was found to be necessary and sufficient to confer the production of at least one of the subject compounds on E. coli.
    Type: Grant
    Filed: August 8, 2003
    Date of Patent: October 3, 2006
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Jo E. Handelsman, Robert M. Goodman, Doreen E. Gillespie, Alan D. Bettermann, Jon C. Clardy, Sean F. Brady
  • Publication number: 20040034088
    Abstract: Disclosed are triaryl cationic compounds that exhibit broad spectrum antibiotic and antifungal activity, pharmaceutical compositions containing the compounds, and methods of treating bacterial and fungal infections using the compounds. The compounds were initially isolated by screening a 25,000-member bacterial artificial chromosome (BAC) library of environmental (eDNA) from soil. At least one clone produced a dark brown melanin-like compound that was found to have antibiotic activity. The compounds were isolated and synthesized de novo. From within the positive clone, a single open reading frame that shares extensive sequence similarity with members of the 4-hydroxyphenylpyruvate family of enzymes was found to be necessary and sufficient to confer the production of at least one of the subject compounds on E. coli.
    Type: Application
    Filed: August 8, 2003
    Publication date: February 19, 2004
    Inventors: Jo E. Handelsman, Robert M. Goodman, Doreen E. Gillespie, Alan D. Bettermann, Jon C. Clardy, Sean F. Brady
  • Publication number: 20010047029
    Abstract: Disclosed are triaryl cationic compounds that exhibit broad spectrum antibiotic and antifungal activity, pharmaceutical compositions containing the compounds, and methods of treating bacterial and fungal infections using the compounds. The compounds were initially isolated by screening a 25,000-member bacterial artificial chromosome (BAC) library of environmental (eDNA) from soil. At least one clone produced a dark brown melanin-like compound that was found to have antibiotic activity. The compounds were isolated and synthesized de novo. From within the positive clone, a single open reading frame that shares extensive sequence similarity with members of the 4-hydroxyphenylpyruvate family of enzymes was found to be necessary and sufficient to confer the production of at least one of the subject compounds on E. coli.
    Type: Application
    Filed: February 23, 2001
    Publication date: November 29, 2001
    Inventors: Jo E. Handelsman, Robert M. Goodman, Doreen E. Gillespie, Alan D. Bettermann, Jon C. Clardy, Sean F. Brady